Cite
HARVARD Citation
Marumo, A. et al. (2022). Cyclophosphamide‐induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less. Asia-Pacific journal of clinical oncology. 18 (5), pp. e507-e514. [Online].